ABSTRACT OBJECTIVES This study sought to describe the impact of statins on individual coronary atherosclerotic plaques.
However, intravascular techniques are subject to calcium shadowing and thus must rely on semiquantitative indices (5) . Additionally, the generalizability of intravascular ultrasonography data to a lower risk population beyond secondary prevention population or advanced coronary disease (CAD), or beyond 24-months, is unknown because the invasiveness of the method applied has limited the study population to those patients who are at relatively high risk or who already have advanced CAD (6) (7) (8) . Prior serial coronary computed tomography angiography (CTA) studies are limited to their number and qualitative methods (4, 9) .
To address this knowledge gap, we prospectively enrolled a large multinational cohort of consecutive patients with suspected CAD who underwent serial coronary CTA at a minimum of 2-year interscan intervals to determine the long-term effects of statins on plaque progression and calcification in a low-risk patient population. 
Lee et al. CTA-1 and coronary CTA-2 were assessed using paired t-tests.
To account for the effect of common factors in clustered lesions within a single patient, marginal
Cox models for multivariate failure times were used to determine the association between statin use and progression of coronary atherosclerosis and reported in terms of hazard ratios (HRs) and 95%
confidence intervals (CI) (22) . Multivariate adjustment was performed for known CAD risk factors, for Values are mean AE SD, n (%), or median (interquartile range).
CAD ¼ coronary artery disease; CTA ¼ computed tomography angiography.
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RESULTS STUDY POPULATION AND BASELINE CHARACTER-
ISTICS. The study population consisted of 1,255 patients (60 AE 9 years of age; 56.7% men) ( Table 1) .
At coronary CTA-1, patients presented mainly for 1 or more cardiac symptoms (97%), and the major reason for undergoing coronary CTA-2 was persistent or worsening cardiac symptoms (64%) (Online Table 2 ). The interscan interval between coronary CTAs was 3.8 AE 1.6 years (median 3.4 years; interquartile range: 2.6 to 4.8 years). Both the tube voltage and the tube current decreased at coronary CTA-2 compared with those at coronary CTA-1 (Online Table 2 ).
Between coronary CTA-1 and coronary CTA-2, 102 patients (8.1%) experienced revascularization (11 surgical and 92 percutaneous coronary interventions); 6 statin-naive patients and 96 statintaking patients (p < 0.001). Values are mean AE SD or n (%), unless otherwise specified. *High-risk plaque is defined as a lesion with $2 features indicative of positive arterial remodeling, low-attenuation plaque, or spotty calcification. †Noncalcified PAV is the summation of fibrous, fibro-fatty, and low-attenuation PAV.
%DS ¼ percentage of diameter stenosis; PAV ¼ percent atheroma volume. .
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